References
- Shulman GI. Cellular mechanisms of insulin resistance. J. Clin. Invest.106, 171–176 (2000).
- Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature414, 799–806 (2001).
- Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. β-cell adaptation and decompensation during the progression of diabetes. Diabetes50, S154–S159 (2001).
- Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet β cells in diabetes. J. Biol. Chem.279, 42351–42354 (2004).
- Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes44, 863–870 (1995).
- Poitout V, Robertson RP. Minireview: secondary β-cell failure in Type 2 diabetes – a convergence of glucotoxicity and lipotoxicity. Endocrinology143, 339–342 (2002).
- Matsuoka T, Kajimoto Y, Watada H et al. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest.99, 144–150 (1997).
- Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem.277, 30010–30018 (2002).
- Kaneto H, Kajimoto Y, Miyagawa J et al. Beneficial effects of antioxidants for diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes48, 2398–2406 (1999).
- Tanaka Y, Gleason CE, Tran POT, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl Acad. Sci. USA96, 10857–10862 (1999).
- Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocrine Rev.23, 599–622 (2002).
- Aridor M, Balch WE. Integration of endoplasmic reticulum signaling in health and disease. Nat. Med.5, 745–751 (1999).
- Ron D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest.110, 1383–1388 (2002).
- Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes51, S455–S461 (2002).
- Nakatani Y, Kaneto H, Kawamori D et al. Involvement of ER stress in insulin resistance and diabetes. J. Biol. Chem.280, 847–851 (2004).
- Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science306, 457–461 (2004).
- Ozcan U, Yilmaz E, Ozcan L et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of Type 2 diabetes. Science313, 1137–1140 (2006).
- Kawamori D, Kajimoto Y, Kaneto H et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun N-terminal kinase. Diabetes52, 2896–2904 (2003).
- Hirosumi J, Tuncman G, Chang L, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature420, 333–336 (2002).
- Nakatani Y, Kaneto H, Kawamori D et al. Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem.279, 45803–45809 (2004).
- Kaneto H, Nakatani Y, Miyatsuka T et al. Possible novel therapy for diabetes with cell-permeable JNK inhibitory peptide. Nat. Med.10, 1128–1132 (2004).
- Bonny C, Oberson A, Negri S, Sause C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes50, 77–82 (2001).
- Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science293, 1673–1677 (2001).
- Cai D, Yuan M, Frantz DF et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med.11, 183–190 (2005).
- Arkan MC, Hevener AL, Greten FR et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med.11, 191–198 (2005).